About BAGIM

BAGIM is an active community of Boston area scientists bringing together people from diverse fields of modeling and informatics to impact life and health sciences. BAGIM strives to create a forum for great scientific discussions covering a wide range of topics including data management, visualization, computational chemistry, drug discovery, protein structure, molecular modeling, structure-based drug design, data mining, software tools, and the sharing of goals and experiences. Our community is made up of participants from academia, government, and industry whose goal is to engage in the discussion of science involving a synthesis of theory and technology. Discussions sponsored by BAGIM are targeted to the needs and interests of informatics scientists, computational chemists, medicinal chemists, and statisticians. BAGIM also provides opportunities for networking within these disciplines as well as an arena for the dissemination of information of specific interest to the membership.

Thursday, January 16, 2025

Shubham Sharma - Integrating experiments, energetics & structural informatics for de-risking of medicines

 Please join us for a joint BAGIM & SAGIM online event sponsored by CCDC.

Date: January 15, 2025
Time: 10 am PT/1 pm ET/6 pm BT
Speaker: Shubham Sharma

Title: Integrating experiments, energetics & structural informatics for de-risking of medicines

Abstract: A critical milestone in the development of a commercial drug product is the selection of the optimum solid form for the active pharmaceutical ingredient (API). Recently, the experimental methods to explore the solid form landscape have been supplemented by computational methods based on relative energies & structural informatics. In particular, the informatics-based assessment, dubbed as a “Health Check”, is a digital risk assessment that leverages a database of crystal structures to assign risk to the targeted solid form by comparing structural aspects of the target structure to databased-derived knowledge. Herein, I describe the use of few approaches to analyze four competing polymorphs of a myeloperoxidase (MPO) inhibitor with conformational flexibility and multiple plausible hydrogen bond networks.

Bio: Dr Shubham Sharma is a computational materials scientist at Pfizer and currently leads the solid form design center (SFDC) interface between Pfizer-CCDC for de-risking medicines using structural informatics-based techniques. Shubham joined Pfizer in 2022 and currently serves as a subject matter expert for various modeling deliverables at the Materials Sciences division. Shubham earned his PhD from Brown University, RI in 2021 followed by a postdoctoral fellowship at the Lawrence Livermore National Laboratory, CA where he contributed to the field of computational catalysis, renewable energies, and material degradation.

No comments:

Post a Comment